GlassScriptPhysician profile
Philip Anthony Basala
NPI 1558376137
$4,042.44
in general payments reported to CMS, 2019-2025
25 companies · $49.34 in 2025
The $49.34 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,140 · 2020: $711 · 2021: $891 · 2022: $160 · 2023: $160 · 2024: $932 · 2025: $49.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $809 · Food and Beverage: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $808.60 |
| Food and Beverage | $332.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $931.55 | 2024 | Gelpoint V-Path |
| Abbvie INC. | $662.05 | 2019-2022 | |
| Allergan, INC. | $647.25 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $410.26 | 2019-2022 | |
| Amgen INC. | $174.66 | 2019-2020 | |
| Astellas Pharma US INC | $158.33 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $133.93 | 2019-2021 | |
| Pfizer INC. | $102.42 | 2019-2021 | |
| Caldera Medical, INC | $92.59 | 2023 | Desara |
| Radius Health, INC. | $86.88 | 2019-2021 | |
| Ironwood Pharmaceuticals, INC | $86.82 | 2019-2020 | |
| Axonics, INC. | $85.88 | 2021-2022 | |
| Medtronic, INC. | $67.31 | 2023 | Interstim |
| Hologic Sales and Service, LLC | $59.27 | 2019-2020 | |
| Ethicon US, LLC | $58.06 | 2019-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $45.58 | 2019-2020 | |
| Valencia Technologies Corporation | $35.36 | 2025 | Ecoin Device Kit |
| Duchesnay USA Incorporated | $33.58 | 2019 | |
| Covidien LP | $31.80 | 2019 | |
| Medtronic USA, INC. | $31.27 | 2020 | |
| Amag Pharmaceuticals, INC. | $27.98 | 2019 | |
| Aspira Women'S Health INC | $27.19 | 2021 | |
| Boston Scientific Corporation | $19.68 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $18.76 | 2019 | |
| Glaxosmithkline, LLC. | $13.98 | 2025 | Arexvy, Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Basala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.